C

Crinetics Pharmaceuticals
D

CRNX

53.970
USD
0.45
(0.84%)
Market Closed
Volume
20,394
EPS
-4
Div Yield
-
P/E
-15
Market Cap
5,005,049,729
OverviewSignalsIdeasNews
Related Instruments
    A
    ADPT
    -0.10000
    (-1.56%)
    6.31000 USD
    B
    BNGO
    0.00010
    (0.05%)
    0.20010 USD
    C
    CRIS
    0.15000
    (4.84%)
    3.25000 USD
    H
    HRTX
    0.04000
    (2.55%)
    1.61000 USD
    L
    LPX
    -0.520
    (-0.50%)
    103.990 USD
    M
    MGNX
    0.04000
    (1.25%)
    3.23000 USD
    P
    PTCT
    -0.660
    (-1.43%)
    45.540 USD
    S
    STOK
    -0.070
    (-0.60%)
    11.610 USD
    X
    XERS
    -0.07000
    (-2.01%)
    3.41000 USD
    More
News

Title: Crinetics Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.